Mid-frontal brain folds key to schizophrenia: Zurich study finds
HQ Team February 27, 2025: The uniformity of brain folding in the mid-frontal area suggests a developmental trait common to people with schizophrenia,.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team February 27, 2025: The uniformity of brain folding in the mid-frontal area suggests a developmental trait common to people with schizophrenia,.
HQ Team February 27, 2025: West Africa’s cocoa-producing region is facing a climate crisis, with rising temperatures, threatening the quantity and quality of.
HQ Team February 27, 2025: A study published in The New England Journal of Medicine (NEJM) reveals that administration of the oral drug.
Eli Lilly will set up four new pharmaceutical manufacturing facilities in the US for $27 billion to further bolster its supply chains, according.
Robots can teach themselves how to move by watching their motions through a camera, similar to looking at a mirror, and also overcome.
The World Health Organization is crowdsourcing to fund its health programs by urging individuals globally to donate to the ‘1 Dollar 1 World.
AstraZeneca Plc.’s end-stage trials of its investigational drug for advanced breast cancer have increased survival rates in patients, results show, according to the.
A mystery illness sweeping over Congo has killed 53 people and infected 400 more, with an initial probe tracking the outbreak to three.
Eli Lilly and Company cut the prices of its weight-loss drug Zepbound, available in single-dose vials, in a bid to end compounding companies from.
King’s and University College of London researchers have developed an artificial intelligence tool that can detect 64% of brain abnormalities, that radiologists miss,.